199 related articles for article (PubMed ID: 33780214)
21. Treatment of unresectable extrahepatic cholangiocarcinoma using hematoporphyrin photodynamic therapy: A prospective study.
Yang J; Shen H; Jin H; Lou Q; Zhang X
Photodiagnosis Photodyn Ther; 2016 Dec; 16():110-118. PubMed ID: 27720942
[TBL] [Abstract][Full Text] [Related]
22. Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma.
Lee TY; Cheon YK; Shim CS; Cho YD
World J Gastroenterol; 2012 Oct; 18(39):5589-94. PubMed ID: 23112552
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Radiofrequency Ablation Plus Stent Versus Stent-alone Treatments for Malignant Biliary Strictures: A Systematic Review and Meta-analysis.
Khizar H; Hu Y; Wu Y; Ali K; Iqbal J; Zulqarnain M; Yang J
J Clin Gastroenterol; 2023 Apr; 57(4):335-345. PubMed ID: 36628465
[TBL] [Abstract][Full Text] [Related]
24. The usefulness of endobiliary radiofrequency ablation before metal stent placement in unresectable malignant hilar obstruction.
Oh D; Chong J; Song TJ; Park DH; Lee SS; Seo DW; Lee SK; Kim MH
J Gastroenterol Hepatol; 2022 Nov; 37(11):2083-2090. PubMed ID: 35869749
[TBL] [Abstract][Full Text] [Related]
25. Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma.
Höblinger A; Gerhardt T; Gonzalez-Carmona MA; Hüneburg R; Sauerbruch T; Schmitz V
Eur J Med Res; 2011 Sep; 16(9):391-5. PubMed ID: 22024438
[TBL] [Abstract][Full Text] [Related]
26. Longterm outcome of photodynamic therapy compared with biliary stenting alone in patients with advanced hilar cholangiocarcinoma.
Cheon YK; Lee TY; Lee SM; Yoon JY; Shim CS
HPB (Oxford); 2012 Mar; 14(3):185-93. PubMed ID: 22321037
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy for unresectable cholangiocarcinoma: a comparative effectiveness systematic review and meta-analyses.
Leggett CL; Gorospe EC; Murad MH; Montori VM; Baron TH; Wang KK
Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):189-95. PubMed ID: 22959798
[TBL] [Abstract][Full Text] [Related]
28. Endoscopic Retrograde Cholangiopancreatography-Guided Ablation for Cholangiocarcinoma.
Buerlein RCD; Wang AY
Gastrointest Endosc Clin N Am; 2019 Apr; 29(2):351-367. PubMed ID: 30846158
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Intraductal RFA Plus Stent versus Stent-Only Treatment for Unresectable Perihilar Cholangiocarcinoma-A Systematic Review and Meta-Analysis.
de Jong DM; Fritzsche JA; Audhoe AS; Yi SSL; Bruno MJ; Voermans RP; van Driel LMJW
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565209
[TBL] [Abstract][Full Text] [Related]
30. Impact of endobiliary radiofrequency ablation on biliary drainage in patients with malignant biliary strictures treated with uncovered self-expandable metal stents: a randomized controlled multicenter trial.
Albers D; Schmidt A; Schiemer M; Caca K; Wannhoff A; Sauer P; Wiesweg M; Schumacher B; Dechene A
Gastrointest Endosc; 2022 Dec; 96(6):970-979. PubMed ID: 35667389
[TBL] [Abstract][Full Text] [Related]
31. Endoscopic radiofrequency ablation plus a novel oral 5-fluorouracil compound versus radiofrequency ablation alone for unresectable extrahepatic cholangiocarcinoma.
Yang J; Wang J; Zhou H; Wang Y; Huang H; Jin H; Lou Q; Shah RJ; Zhang X
Gastrointest Endosc; 2020 Dec; 92(6):1204-1212.e1. PubMed ID: 32437711
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous endobiliary radiofrequency ablation and stents in management of hepatocellular carcinoma with bile duct tumor thrombus: Initial single-institution experience.
Cui W; Xu R; Wang Y; Shi F; Li J; Chen X
Asia Pac J Clin Oncol; 2020 Aug; 16(4):259-265. PubMed ID: 32368843
[TBL] [Abstract][Full Text] [Related]
33. Multimodal treatment with endoscopic ablation and systemic therapy for cholangiocarcinoma.
Nabi Z; Żorniak M; Reddy DN
Best Pract Res Clin Gastroenterol; 2024 Feb; 68():101893. PubMed ID: 38522890
[TBL] [Abstract][Full Text] [Related]
34. Benefits and safety of photodynamic therapy in patients with hilar cholangiocarcinoma: A meta-analysis.
Chen P; Yang T; Shi P; Shen J; Feng Q; Su J
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102712. PubMed ID: 34995788
[TBL] [Abstract][Full Text] [Related]
35. Percutaneous intraductal radiofrequency ablation combined with biliary stent placement for treatment of malignant biliary obstruction.
Yu T; Zhang W; Li C; Wang C; Gong G; Wang L; Li G; Chen Y; Wang X
Abdom Radiol (NY); 2020 Nov; 45(11):3690-3697. PubMed ID: 32277241
[TBL] [Abstract][Full Text] [Related]
36. The safety and efficacy of percutaneous intraductal radiofrequency ablation in unresectable malignant biliary obstruction: A single-institution experience.
Cui W; Fan W; Lu M; Zhang Y; Yao W; Li J; Wang Y
BMC Cancer; 2017 Apr; 17(1):288. PubMed ID: 28438130
[TBL] [Abstract][Full Text] [Related]
37. Updated evidence on the clinical impact of endoscopic radiofrequency ablation in the treatment of malignant biliary obstruction.
Inoue T; Yoneda M
Dig Endosc; 2022 Jan; 34(2):345-358. PubMed ID: 34107114
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis.
Lu Y; Liu L; Wu JC; Bie LK; Gong B
Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):718-24. PubMed ID: 26070572
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma.
Wang Y; Cui W; Fan W; Zhang Y; Yao W; Huang K; Li J
Oncotarget; 2016 Aug; 7(33):53911-53920. PubMed ID: 27322076
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma.
Dumoulin FL; Gerhardt T; Fuchs S; Scheurlen C; Neubrand M; Layer G; Sauerbruch T
Gastrointest Endosc; 2003 Jun; 57(7):860-7. PubMed ID: 12776033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
